Improving monitoring of cardiac function in critical illness: from advanced echocardiographic technology to metabolic and biochemical biomarkers predicting myocardial dysfunction.
Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?
Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice
Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy